Opportunity Overview
To support UG3/UH3 phased, cooperative agreement research applications to plan and implement clinical trials within the mission of the National Institute of Dental and Craniofacial Research (NIDCR)
This is one of 123 active United States Pharmaceuticals opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | National Institutes of Health |
|---|---|
| Country | United States |
| Category | Pharmaceuticals |
| NAICS | 93.121 |
| Published | October 23, 2024 |
| Procurement stage | Request for Proposal (RFP) |
| Response due | January 06, 2028 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: U.S. Government (Simpler.Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.
Related Opportunities in United States
See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Pharmaceuticals intelligence report in your inbox
A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.